A Response to: Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort

Detalles Bibliográficos
Autores principales: Ruiz-Antorán, Belén, Sancho-López, Aránzazu, Torres, Ferrán, Fernández-Cruz, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083088/
https://www.ncbi.nlm.nih.gov/pubmed/33928532
http://dx.doi.org/10.1007/s40121-021-00444-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083088/
https://www.ncbi.nlm.nih.gov/pubmed/33928532
http://dx.doi.org/10.1007/s40121-021-00444-4

Ejemplares similares